Learn how chronic kidney disease and diabetes accelerate heart risk, with new research revealing early warning signs.

The kidneys are essential organs for the proper functioning of our bodies, yet we often do not get the proper attention ...

Expanded Ozempic approval in the U.S. could transform how doctors treat patients with chronic kidney disease, which involves ...

In line with trial results, real-world data suggest GLP-1 receptor agonists have certain benefits in patients with moderate to severe chronic kidney disease (CKD).

A patient-centered approach is recommended to tailor to individual needs when calculating individual protein needs.

Using patient kidney biopsies, the team developed a new method to measure glycocalyx thickness, confirming that the layer is ...

Body-weight cycling, sometimes referred to as yo-yo dieting, may be harmful to the kidneys for people with type 1 diabetes, ...

The trial followed 3,533 people in 28 countries with type 2 diabetes and moderate to severe kidney disease. The results demonstrate delayed progression of CKD in the semaglutide group with a 24% ...

Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. | Novo Nordisk’s cannabinoid CB1 receptor blocker has run into another problem. Months after sharing obesity data that ...

Body-weight cycling (also known as yo-yo dieting) has been shown to significantly increase the risk of kidney disease in ...